OBJECTIVES: Since the pituitary gland measures 3-8 mm, imaging with the highest possible spatial resolution is important for the detection of even smaller lesions such as those seen in Cushing's disease. In the current feasibility study, we tested a multi-sequence MRI protocol to visualize the pituitary gland in high resolution at 7.0 Tesla (7.0 T). METHODS: Ten healthy volunteers were examined with a 7.0 T pituitary gland protocol. The protocol consisted of a T1-weighted magnetization-prepared inversion recovery (MPIR) turbo spin-echo (TSE) sequence and a T2-weighted TSE sequence. Additionally, this protocol was tested in five patients with clinical and biochemical suspicion of a microadenoma. RESULTS: The dedicated protocol was successful in visualizing normal pituitary anatomy. At 7.0 T compared to 1.5 T, four times as many slices covered the pituitary gland in sagittal and coronal direction. In three patients, a lesion was diagnosed at 7.0 T, and was confirmed by histopathology to be a microadenoma. CONCLUSION: Head-to-head comparisons of 7.0 T with 1.5 T and 3.0 T are needed with larger samples of patients and with imaging times feasible for clinical settings. However, the current study suggests that high-resolution 7.0 T MRI of the pituitary gland may provide new perspectives when used as a second-line diagnostic examination in the specific context of Cushing's disease. KEY POINTS: • 7.0 T MRI enables ultra-high-resolution imaging of the pituitary gland. • 7.0 T MRI is appropriate to visualize normal pituitary gland anatomy. • The pituitary protocol consists of a T 1 -MPIR-TSE and a T 2 -TSE sequence. • In four patients, a suspected ACTH-producing microadenoma was visualized at 7.0 T. • Histopathology confirmed three of four lesions to be ACTH-producing microadenomas.
OBJECTIVES: Since the pituitary gland measures 3-8 mm, imaging with the highest possible spatial resolution is important for the detection of even smaller lesions such as those seen in Cushing's disease. In the current feasibility study, we tested a multi-sequence MRI protocol to visualize the pituitary gland in high resolution at 7.0 Tesla (7.0 T). METHODS: Ten healthy volunteers were examined with a 7.0 T pituitary gland protocol. The protocol consisted of a T1-weighted magnetization-prepared inversion recovery (MPIR) turbo spin-echo (TSE) sequence and a T2-weighted TSE sequence. Additionally, this protocol was tested in five patients with clinical and biochemical suspicion of a microadenoma. RESULTS: The dedicated protocol was successful in visualizing normal pituitary anatomy. At 7.0 T compared to 1.5 T, four times as many slices covered the pituitary gland in sagittal and coronal direction. In three patients, a lesion was diagnosed at 7.0 T, and was confirmed by histopathology to be a microadenoma. CONCLUSION: Head-to-head comparisons of 7.0 T with 1.5 T and 3.0 T are needed with larger samples of patients and with imaging times feasible for clinical settings. However, the current study suggests that high-resolution 7.0 T MRI of the pituitary gland may provide new perspectives when used as a second-line diagnostic examination in the specific context of Cushing's disease. KEY POINTS: • 7.0 T MRI enables ultra-high-resolution imaging of the pituitary gland. • 7.0 T MRI is appropriate to visualize normal pituitary gland anatomy. • The pituitary protocol consists of a T 1 -MPIR-TSE and a T 2 -TSE sequence. • In four patients, a suspected ACTH-producing microadenoma was visualized at 7.0 T. • Histopathology confirmed three of four lesions to be ACTH-producing microadenomas.
Authors: Anja G van der Kolk; Jaco J M Zwanenburg; Manon Brundel; Geert-Jan Biessels; Fredy Visser; Peter R Luijten; Jeroen Hendrikse Journal: Stroke Date: 2011-07-14 Impact factor: 7.914
Authors: David B Stobo; Robert S Lindsay; John M Connell; Laurence Dunn; Kirsten P Forbes Journal: Clin Endocrinol (Oxf) Date: 2011-11 Impact factor: 3.478
Authors: Val M Runge; Mittun C Patel; Shannon S Baumann; Alexander B Simonetta; John A Ponzo; Walter S Lesley; Gordon W Calderwood; L G Naul Journal: Invest Radiol Date: 2006-02 Impact factor: 6.016
Authors: Carsten Krautmacher; Winfried A Willinek; Henriette J Tschampa; Mark Born; Frank Träber; Jürgen Gieseke; Hans J Textor; Hans H Schild; Christiane K Kuhl Journal: Radiology Date: 2005-10-19 Impact factor: 11.105
Authors: Thomas F Barrett; Hadrien A Dyvorne; Francesco Padormo; Puneet S Pawha; Bradley N Delman; Raj K Shrivastava; Priti Balchandani Journal: World Neurosurg Date: 2017-03-27 Impact factor: 2.104
Authors: Alexandra A J de Rotte; Amy Groenewegen; Dik R Rutgers; Theo Witkamp; Pierre M J Zelissen; F J Anton Meijer; Erik J van Lindert; Ad Hermus; Peter R Luijten; Jeroen Hendrikse Journal: Eur Radiol Date: 2015-05-20 Impact factor: 5.315
Authors: Siegfried Trattnig; Elisabeth Springer; Wolfgang Bogner; Gilbert Hangel; Bernhard Strasser; Barbara Dymerska; Pedro Lima Cardoso; Simon Daniel Robinson Journal: Neuroimage Date: 2016-11-13 Impact factor: 6.556